Citybuzz

Citybuzz

Citybuzz is a vibrant local lifestyle and news media outlet. While primarily reporting on community events and entertainment it also actively covers business innovation and tech trends acting as a window connecting local audiences with modern digital lifestyle trends.

Citybuzz Tarafından Yazılan Makaleler

Hydrogen Fuel Cell Company Symbio’s Temecula Expansion Highlights Region’s Clean Tech Growth

Hydrogen Fuel Cell Company Symbio’s Temecula Expansion Highlights Region’s Clean Tech Growth

Symbio expands hydrogen fuel cell operations in Temecula with EDC support, boosting clean tech innovation in Southern California wine country region through strategic

Leonteq Shareholders Approve All Board Proposals at 2026 Annual General Meeting

Leonteq Shareholders Approve All Board Proposals at 2026 Annual General Meeting

Leonteq AG's 2026 AGM saw shareholders approve all board proposals, including re-elections and new members. Key reports and governance changes were endorsed, highlighting

LION E-Mobility AG Reports Strong Financial Turnaround and Growth in 2025, Driven by Battery Market Recovery

LION E-Mobility AG Reports Strong Financial Turnaround and Growth in 2025, Driven by Battery Market Recovery

LION E-Mobility AG reports 68% revenue growth to EUR 28.3M in 2025, with EBITDA turning positive at EUR 7.5M. New NMC+ battery packs and expanding BESS pipeline

Springer Nature CFO Alexandra Dambeck to Depart by End of 2026

Springer Nature CFO Alexandra Dambeck to Depart by End of 2026

Alexandra Dambeck, CFO of Springer Nature, announces departure by end of 2026. Learn about the leadership transition, company's future plans, and impact on research

Cardio Diagnostics Holdings Advances AI-Powered Cardiovascular Testing with Expanded Access and Reimbursement

Cardio Diagnostics Holdings Advances AI-Powered Cardiovascular Testing with Expanded Access and Reimbursement

Cardio Diagnostics Holdings uses AI and biomarkers to revolutionize heart disease detection with simple blood tests. Learn about their CMS-approved technology and

Soligenix Reports 2025 Progress on Rare Disease Pipeline with Key Phase 3 Trial Milestones Approaching

Soligenix Reports 2025 Progress on Rare Disease Pipeline with Key Phase 3 Trial Milestones Approaching

Soligenix reports 2025 results, advancing HyBryte™ for cutaneous T-cell lymphoma and orphan drug designation for Behçet’s Disease. Explore rare disease pipeline

Datavault AI Partners with Coppercore to Tokenize $100 Million in Copper Resources

Datavault AI Partners with Coppercore to Tokenize $100 Million in Copper Resources

Datavault AI partners with Coppercore to tokenize $100M+ in copper resources via blockchain. Coppercoin™ tokens represent physical copper, enabling fractional investment

LIXTE Biotechnology’s Clinical-Stage PP2A Inhibitor LB-100 Shows Potential to Enhance Cancer Treatment Efficacy

LIXTE Biotechnology’s Clinical-Stage PP2A Inhibitor LB-100 Shows Potential to Enhance Cancer Treatment Efficacy

LIXTE Biotechnology's LB-100 is the world's only clinical-stage PP2A inhibitor, enhancing cancer treatment effectiveness while disrupting tumor repair systems in

CMX Gold & Silver Corp. Advances Exploration of Idaho’s Clayton Silver Project, Citing Multi-Vein Potential

CMX Gold & Silver Corp. Advances Exploration of Idaho’s Clayton Silver Project, Citing Multi-Vein Potential

CMX Gold & Silver Corp. advances exploration at Clayton Silver project in Idaho, targeting undiscovered silver veins in historic mining district with modern geological

Soligenix’s HyBryte Therapy Gains Scientific Validation Through Peer-Reviewed Publication

Soligenix’s HyBryte Therapy Gains Scientific Validation Through Peer-Reviewed Publication

Soligenix publishes HyBryte™ therapy clinical summary in peer-reviewed journal, enhancing credibility for cutaneous T-cell lymphoma treatment through scientific